Earnings History Data for InflaRx (IFRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
InflaRx
InflaRx N.V. is a clinical-stage biopharmaceutical company. It focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. InflaRx N.V. is based in Germany.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21-03-2024 | PM | IFRX | InflaRx | 76.00 | -0.30 | -0.20 | 0.00 | InflaRx reports FY results [3/21/2024 7:09 AM] |
1.51 | -0.18 (-10.65%) |
1.40 | -0.29 (-17.16%) |
1.14 - 7.25 | 527,317 | 140,000 | 76,862 | ||
| 01-11-2023 | PM | IFRX | InflaRx | 76.00 | -0.14 | -0.29 | 0.00 | InflaRx GAAP EPS of -€0.13 [11/1/2023 7:46 AM] |
1.61 | -0.08 (-4.73%) |
0.0 | 0.0 (0.00%) |
1.45 - 7.25 | 477,908 | 270,000 | 0 | ||
| 10-08-2023 | PM | IFRX | InflaRx | 160.00 | -0.15 | -0.36 | 0.00 | InflaRx GAAP EPS of -€0.14 [8/10/2023 10:26 AM] |
3.96 | 0.31 (8.36%) |
2.71 | -0.94 (-25.75%) |
1.57 - 7.25 | 2,098,833 | 150,000 | 54,090 | ||
| 09-11-2022 | PM | IFRX | InflaRx | 119.00 | -0.18 | -0.36 | 0.00 | InflaRx GAAP EPS of -$0.18 [11/9/2022 8:40 AM] |
2.66 | -0.07 (-2.56%) |
2.59 | -0.14 (-5.13%) |
0.78 - 5.69 | 59,761 | 60,000 | 8,224 | ||
| 05-08-2022 | PM | 7:30 AM ET (Aug 5) |
IFRX | InflaRx N.V. | 59.68 | 0.01 | -0.34 | -0.40 | InflaRx reports Q2 results [8/5/2022 7:28 AM] |
2.91 | -0.16 (-5.21%) |
3.00 | -0.07 (-2.28%) |
0.78 - 5.69 | 301,629 | 1,500,000 | 456 | |
| 12-05-2022 | PM | IFRX | InflaRx N.V. | 65.86 | -0.36 | -0.34 | -0.22 | InflaRx GAAP EPS of -€0.32 [5/12/2022 8:21 AM] |
1.46 | 0.09 (6.57%) |
1.31 | -0.06 (-4.38%) |
1.31 - 5.69 | 259,995 | 130,000 | 1,555 | ||
| 05-11-2021 | PM | IFRX | InflaRx N.V. | 209.44 | -0.32 | -0.39 | -0.29 | InflaRx EPS beats by $0.09 [11/5/2021 8:57 AM] |
4.60 | -0.09 (-1.85%) |
4.25 | -0.44 (-9.38%) |
2.23 - 6.88 | 1,298,724 | 14,200,000 | 131,843 | ||
| 12-05-2021 | PM | IFRX | Inflarx N.v. | 147.00 | -0.22 | -0.26 | 0.00 | InflaRx reports Q1 results [5/12/2021 7:41 AM] |
2.89 | -0.58 (-16.71%) |
3.32 | -0.15 (-4.32%) |
2.84 - 9.70 | 1,720,449 | 230,000 | 45,243 | ||
|
||||||||||||||||||
| 25-03-2021 | PM | 7:00 AM ET (Mar 25) |
IFRX | Inflarx N.v. | 187.00 | -0.38 | -0.29 | 0.00 | 3.87 | -0.08 (-2.03%) |
4.00 | 0.05 (1.27%) |
3.35 - 9.70 | 694,727 | 460,000 | 569 | ||
| 29-10-2020 | PM | IFRX | Inflarx N.v. | 111.00 | -0.29 | -0.41 | 0.00 | InflaRx reports Q3 results [10/29/2020 7:29 AM] |
4.11 | 0.27 (7.03%) |
0.0 | 0.0 (0.00%) |
2.26 - 9.70 | 211,669 | 220,114 | 0 | ||
|
|
||||||||||||||||||